Anti-diabetic Agents (Oral) - Index

Medications listed in the tables and non-FDA approved indications included in these retrospective criteria are not indicative of Texas Vendor Drug Program formulary coverage.

• Revision history
  • Oct. 25, 2024
  • Oct. 21, 2022
  • Sept. 2020
  • Sept. 2018
  • Sept. 2016
  • Aug. 2014
  • July 2014
  • Oct. 2012
  • Jan. 2011
  • Feb. 2008
  • Nov. 2007
  • June 2003
  • July 2002
  • Sept. 2001
  • June 2001
  • June 2000
  • July 1999
  • June 1998
  • June 1997
  • June 1996
  • Sept. 1995
  • April 1994 (initially developed)